Prof. Wilson holds the Chair in Drug Metabolism and Molecular Toxicology.
Ian Wilson trained as a biochemist at the University of Manchester Institute of Science and Technology, going on to a PhD at Keele University on insect moulting hormones. After this he worked in the Pharmaceutical industry, most recently as a Senior Principal Scientist in the Dept of Drug Metabolism and Pharmacokinetics at the AstraZeneca Research site at Alderley Park in Cheshire (UK), joining Imperial College in 2012. He is the author, or co-author, of some 480 papers or reviews, and has received a number of awards in separation and analytical science from the Royal Society of Chemistry, including the Gold Medal of the Analytical Division (2005) and most recently the Knox Medal of the RSC Separation Science Group (2012). He received the Jubilee Medal of the Chromatographic Society in 1994 and gave the inaugural Desty Memorial lecture for Innovation in Separation Science in1996. His research is directed towards the development of hyphenated techniques in chromatography and their application to problems in drug metabolism, toxicology and metabonomics
et al., 2017, The pharmacokinetics and metabolism of lumiracoxib in chimeric humanized and murinized FRG mice., Biochem Pharmacol, Vol:135, Pages:139-150
Wilson ID, Nicholson JK, 2016, Gut microbiome interactions with drug metabolism, efficacy, and toxicity., Transl Res, Vol:179, Pages:204-222
et al., 2016, Targeted Metabolic Profiling of the Tg197 Mouse Model Reveals Itaconic Acid as a Marker of Rheumatoid Arthritis., J Proteome Res, Vol:15, Pages:4579-4590
et al., 2016, Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities., Embo Mol Med, Vol:8, Pages:1134-1142
et al., 2018, Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective, Toxicology Research, ISSN:2045-452X